Results of screening a large group of intercollegiate competitive athletes for cardiovascular disease

Cardiology Branch, National Institutes of Health, Bethesda, Maryland 20892.

To determine the feasibility of detecting cardiovascular disease in a large group of young competitive athletes, a prospective screening evaluation of intercollegiate student athletes was undertaken at the University of Maryland. Initial clinical screening (including personal and family history, physical examination and 12 lead electrocardiogram) was performed in 501 athletes. Ninety of these subjects had positive findings on one or more of the three studies and agreed to further cardiologic evaluation. The vast majority (75 [84%] of 90) had no definitive evidence of cardiovascular disease, although 1 athlete had mild systemic hypertension and 14 (15%) had echocardiographic evidence of relatively mild mitral valve prolapse that had not been previously suspected. In three athletes with relatively mild ventricular septal hypertrophy (14 to 15 mm), it was not possible to discern with absolute certainty whether the wall thickening was a manifestation of hypertrophic cardiomyopathy or secondary to athletic conditioning ("athlete heart"). Therefore, this screening protocol identified no athletes with definite evidence of hypertrophic cardiomyopathy, Marfan's syndrome or other cardiovascular diseases that convey a significant potential risk for sudden death or disease progression during athletic activity. This failure to identify such diseases could have been due to a lack of sensitivity of the screening tests or to the low frequency with which these diseases occur in youthful healthy athletes. A systematic preparticipation screening program (such as the present one) does not appear to be an efficient means of detecting clinically important cardiovascular disease in young athletes.

This article has been cited by other articles:

				L Stefani, G Galanti, L Toncelli, P Manetti, M C Vono, M Rizzo, and N Maffulli Bicuspid aortic valve in competitive athletes Br. J. Sports Med., January 1, 2008; 42(1): 31 - 35. [Abstract] [Full Text] [PDF]

				B. R. Chaitman An Electrocardiogram Should Not Be Included in Routine Preparticipation Screening of Young Athletes Circulation, November 27, 2007; 116(22): 2610 - 2615. [Full Text] [PDF]

				B. J. Maron, P. D. Thompson, M. J. Ackerman, G. Balady, S. Berger, D. Cohen, R. Dimeff, P. S. Douglas, D. W. Glover, A. M. Hutter Jr, et al. Recommendations and Considerations Related to Preparticipation Screening for Cardiovascular Abnormalities in Competitive Athletes: 2007 Update: A Scientific Statement From the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation Circulation, March 27, 2007; 115(12): 1643 - 1655. [Full Text] [PDF]

				P. Angelini Coronary Artery Anomalies: An Entity in Search of an Identity Circulation, March 13, 2007; 115(10): 1296 - 1305. [Abstract] [Full Text] [PDF]

				D. Corrado, A. Pelliccia, H. H. Bjornstad, L. Vanhees, A. Biffi, M. Borjesson, N. Panhuyzen-Goedkoop, A. Deligiannis, E. Solberg, D. Dugmore, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology Eur. Heart J., March 1, 2005; 26(5): 516 - 524. [Abstract] [Full Text] [PDF]

				E. E. Coris, F. Sahebzamani, S. Walz, and A. M. Ramirez Automated External Defibrillators in National Collegiate Athletic Association Division I Athletics Am. J. Sports Med., April 1, 2004; 32(3): 744 - 754. [Abstract] [Full Text] [PDF]

				B. J. Maron Sudden Death in Young Athletes N. Engl. J. Med., September 11, 2003; 349(11): 1064 - 1075. [Full Text] [PDF]

				L. J. Krovetz Preventing sudden death in athletes AAP News, December 1, 2002; 21(6): 292 - 292. [Full Text] [PDF]

				J.R.T.C Roelandt A personal ultrasound imager (ultrasound stethoscope). A revolution in the physical cardiac diagnosis! Eur. Heart J., April 1, 2002; 23(7): 523 - 527. [Full Text] [PDF]

				J. Erdmann, J.o. Raible, J. Maki-Abadi, M. Hummel, J. Hammann, B. Wollnik, E. Frantz, E. Fleck, R. Hetzer, and V. Regitz-Zagrosek Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy J. Am. Coll. Cardiol., August 1, 2001; 38(2): 322 - 330. [Abstract] [Full Text] [PDF]

				J. A. Davis, F. Cecchin, T. K. Jones, and M. A. Portman Major coronary artery anomalies in a pediatric population: incidence and clinical importance J. Am. Coll. Cardiol., February 1, 2001; 37(2): 593 - 597. [Abstract] [Full Text] [PDF]

				C. Basso, B. J. Maron, D. Corrado, and G. Thiene Clinical profile of congenital coronary artery anomalies with origin from the wrong aortic sinus leading to sudden death in young competitive athletes J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1493 - 1501. [Abstract] [Full Text] [PDF]

				F. C. Basilico Cardiovascular Disease in Athletes Am. J. Sports Med., January 1, 1999; 27(1): 108 - 121. [Abstract] [Full Text] [PDF]

				D. Corrado, C. Basso, M. Schiavon, and G. Thiene Screening for Hypertrophic Cardiomyopathy in Young Athletes N. Engl. J. Med., August 6, 1998; 339(6): 364 - 369. [Abstract] [Full Text] [PDF]

				D. W. Glover and B. J. Maron Profile of Preparticipation Cardiovascular Screening for High School Athletes JAMA, June 10, 1998; 279(22): 1817 - 1819. [Abstract] [Full Text] [PDF]

				M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al. ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography Circulation, March 18, 1997; 95(6): 1686 - 1744. [Full Text]

				B. J. Maron, P. D. Thompson, J. C. Puffer, C. A. McGrew, W. B. Strong, P. S. Douglas, L. T. Clark, M. J. Mitten, M. H. Crawford, D. L. Atkins, et al. Cardiovascular Preparticipation Screening of Competitive Athletes: A Statement for Health Professionals From the Sudden Death Committee (Clinical Cardiology) and Congenital Cardiac Defects Committee (Cardiovascular Disease in the Young), American Heart Association Circulation, August 15, 1996; 94(4): 850 - 856. [Full Text]

				B. J. Maron, J. M. Gardin, J. M. Flack, S. S. Gidding, T. T. Kurosaki, and D. E. Bild Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young Adults : Echocardiographic Analysis of 4111 Subjects in the CARDIA Study Circulation, August 15, 1995; 92(4): 785 - 789. [Abstract] [Full Text]

				B. J. Maron, A. Pelliccia, and P. Spirito Cardiac Disease in Young Trained Athletes : Insights Into Methods for Distinguishing Athlete's Heart From Structural Heart Disease, With Particular Emphasis on Hypertrophic Cardiomyopathy Circulation, March 1, 1995; 91(5): 1596 - 1601. [Full Text]

				B. J. Maron Sudden Death in Young Athletes -- Lessons from the Hank Gathers Affair N. Engl. J. Med., July 1, 1993; 329(1): 55 - 57. [Full Text]